Table 1 Clinical and histological features of the nine cases of reported sciatic nerve lymphoma.
| Case | Age | Sex | Side | Histology (criteria set) | Grade | Treatment | Outcome |
|---|---|---|---|---|---|---|---|
| Purohit et al9 | 64 | F | Right | B cell NHL centrocytic (Kiel) | Low | Resection, radiotherapy | Evidence of systemic disease 36 months after clinical onset |
| Pillay et al5 | 61 | M | Left | B cell NHL diffuse large cell (IWF) | Intermed | Radiotherapy | No evidence of disease 12 months after clinical onset |
| Eusebi et al11 | 72 | M | Right | B cell NHL follicular large cell (IWF) | Intermed | Resection, chemotherapy | Died of systemic disease 16 months after clinical onset |
| Kanamori et al6 | 34 | M | Left | T cell NHL lymphoblastic | High | Chemotherapy, radiotherapy | No evidence of disease 30 months after clinical onset |
| Roncaroli et al7 | 44 | M | Left | B cell NHL diffuse large cell (IWF) | Intermed | Radiotherapy, chemotherapy | Died of CNS disease 50 months after clinical onset |
| Quinones‐ Hinojosa et al8 | 52 | M | Right | B cell NHL Burkitt‐like (REAL) | High | Chemotherapy | Died of CNS/PNS disease approx. 18 months after clinical onset |
| Misdraji et al4 | 62 | F | Left | B cell NHL diffuse large cell (REAL) | High | Radiotherapy, chemotherapy | Stable local residual disease 57 months after clinical onset |
| 49 | M | Right | B cell NHL diffuse large cell (REAL) | High | Chemotherapy | Died of CNS disease at 6 months | |
| Present case | 55 | M | Left | B cell NHL diffuse large cell (REAL) | High | Chemotherapy and anti‐CD20 | No evidence of disease 48 months after clinical onset |
CNS, central nervous system; Intermed, intermediate; IWF, International Working Formulation; F, female; M, male; NHL, non‐Hodgkin's lymphoma; PNS, peripheral nervous system; REAL, revised European—American classification of lymphoid neoplasms.